Shabahang Shahrokh 4
4 · Aditx Therapeutics, Inc. · Filed May 28, 2021
Insider Transaction Report
Form 4
Shabahang Shahrokh
DirectorCHIEF INNOVATION OFFICER
Transactions
- Purchase
Common Stock
2021-05-27$2.70/sh+185$500→ 1,015,608 total - Purchase
Common Stock
2021-05-25$2.40/sh+279$670→ 1,015,285 total(indirect: By son) - Purchase
Common Stock
2021-05-25$2.38/sh+138$328→ 1,015,423 total(indirect: By son)
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F2]Fractional amounts have been rounded to the nearest whole number.